by Eric Christianson | Feb 11, 2026 | Cardiovascular Medication and Disease State Clinical Pearls
Fibrates are lipid-lowering agents that are primarily used to reduce triglycerides. They are most beneficial in patients with significantly elevated triglyceride levels, particularly those above 500 mg/dL, where the primary clinical goal is reducing the risk of...
by Eric Christianson | Jan 14, 2024 | Cardiovascular Medication and Disease State Clinical Pearls
Fenofibrate is a lipid-lowering medication indicated as monotherapy to treat primary hyperlipidemia, mixed dyslipidemia, and hypertriglyceridemia. While this medication has been around for many years, its formulation has continued to evolve. The different fenofibrate...
by Eric Christianson | Oct 13, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
Fibrates are a type of amphipathic carboxylic acid that treat hypertriglyceridemia. They work by reducing the liver’s production of VLDL particles that carry triglycerides to tissues and accelerating the body’s removal of triglycerides. Due to this mechanism of...
